• Issue

    Journal of Surgical Oncology: Volume 114, Issue 5

    529-650
    October 1, 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information - Ed Board

  • Page: 529
  • First Published: 21 October 2016
Free Access

Issue Information - TOC

  • Pages: 530-532
  • First Published: 21 October 2016

Research Article

Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base

Alina M. Mateo MD,  Todd A. Pezzi BS,  Mark Sundermeyer MD,  Cynthia A. Kelley MD,  Vicki S. Klimberg MD,  Christopher M. Pezzi MD, 
  • Pages: 533-536
  • First Published: 08 July 2016

Review Article

A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema

Cara Seward BS,  Melissa Skolny MSHA, RN,  Cheryl Brunelle CLT, PT,  Maria Asdourian BS,  Laura Salama MD,  Alphonse G. Taghian MD, PhD, 
  • Pages: 537-542
  • First Published: 08 July 2016

Research Articles

Metastatic pattern of invasive lobular carcinoma of the breast—Emphasis on gastric metastases

Ali El-Hage MD,  Carolanne Ruel MD,  Wahiba Afif MD,  Hussein Wissanji MD,  Jean-Charles Hogue PhD,  Christine Desbiens MD, FRCSC,  Guy Leblanc MD, FRCSC,  Éric Poirier MD, FRCSC, 
  • Pages: 543-547
  • First Published: 12 July 2016

Ductal carcinoma in situ on stereotactic biopsy of suspicious breast microcalcifications: Expression of SPARC (Secreted Protein, Acidic and Rich in Cysteine) can predict postoperative invasion

Bartlomiej Szynglarewicz MD,  Piotr Kasprzak MD,  Piotr Donizy MD,  Przemyslaw Biecek MSc,  Agnieszka Halon MD,  Rafal Matkowski MD, 
  • Pages: 548-556
  • First Published: 20 July 2016

A prognostic model for resectable soft tissue and cutaneous angiosarcoma

Andrew J. Sinnamon MD,  Madalyn G. Neuwirth MD,  Matthew T. McMillan BA,  Brett L. Ecker MD,  Edmund K. Bartlett MD,  Paul J. Zhang MD,  Rachel R. Kelz MD, MSCE,  Douglas L. Fraker MD,  Robert E. Roses MD,  Giorgos C. Karakousis MD, 
  • Pages: 557-563
  • First Published: 04 July 2016

Review Article

Chordomas and chondrosarcomas—The role of radiation therapy

Karen De Amorim Bernstein MD,  Thomas DeLaney MD, 
  • Pages: 564-569
  • First Published: 19 October 2016

Research Articles

Can the ACS-NSQIP surgical risk calculator predict post-operative complications in patients undergoing flap reconstruction following soft tissue sarcoma resection?

Jelena Slump MD,  Peter C. Ferguson MD, MSc,  Jay S. Wunder MD, MSc,  Anthony Griffin MSc,  Harald J. Hoekstra MD, PhD,  Shaghayegh Bagher MSc,  Toni Zhong MD, MHS,  Stefan O.P. Hofer MD, PhD,  Anne C. O'Neill MBBCh, PhD, 
  • Pages: 570-575
  • First Published: 14 September 2016

A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?

Lauren M. Postlewait MD,  Gillian G. Baptiste BA,  Cecilia G. Ethun MD,  Nina Le BS,  Kenneth Cardona MD,  Maria C. Russell MD,  Field F. Willingham MD, MPH,  David A. Kooby MD,  Charles A. Staley MD,  Shishir K. Maithel MD, 
  • Pages: 576-580
  • First Published: 08 July 2016

Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer—Is it indicated?

Ashley N. Krepline BS,  Kathleen K. Christians MD,  Ben George MD,  Paul S. Ritch MD,  Beth A. Erickson MD,  Parag Tolat MD,  Douglas B. Evans MD,  Susan Tsai MD, MHS, 
  • Pages: 581-586
  • First Published: 19 October 2016

Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

Sunhee S. Kim BS,  Eric K. Nakakura MD, PhD,  Zhen J. Wang MD,  Grace E. Kim MD,  Carlos U. Corvera MD,  Hobart W. Harris MD, MPH,  Kimberly S. Kirkwood MD,  Ryutaro Hirose MD,  Margaret A. Tempero MD,  Andrew H. Ko MD, 
  • Pages: 587-596
  • First Published: 21 July 2016

Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence

Giovanni Marchegiani MD,  Stefano Andrianello MD,  Marta Massignani MD,  Giuseppe Malleo MD,  Laura Maggino MD,  Salvatore Paiella MD,  Cristina R. Ferrone MD,  Claudio Luchini MD,  Aldo Scarpa MD,  Paola Capelli MD,  Mari Mino-Kenudson MD,  Keith D. Lillemoe MD,  Claudio Bassi MD,  Carlos Fernàndez-del Castillo MD,  Roberto Salvia MD, PhD, 
  • Pages: 597-601
  • First Published: 29 July 2016

Survival rates in T1 and T2 gastric cancer: A Western report

Naruhiko Ikoma MD,  Mariela Blum MD,  Yi-Ju Chiang MSPH,  Jeannelyn S. Estrella MD,  Sinchita Roy-Chowdhuri MD,  Keith Fournier MD,  Paul Mansfield MD,  Jaffer A. Ajani MD,  Brian D. Badgwell MD, MS, 
  • Pages: 602-606
  • First Published: 20 July 2016

Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis

Taisuke Imamura MD,  Shuhei Komatsu MD, PhD,  Daisuke Ichikawa MD, PhD,  Tsutomu Kawaguchi MD, PhD,  Toshiyuki Kosuga MD, PhD,  Kazuma Okamoto MD, PhD,  Hirotaka Konishi MD, PhD,  Atsushi Shiozaki MD, PhD,  Hitoshi Fujiwara MD PhD,  Eigo Otsuji MD PhD, 
  • Pages: 607-612
  • First Published: 26 August 2016

Chylous ascites after lymphadenectomy for gynecological malignancies

Falk C. Thiel MD,  Parnian Parvanta MD,  Alexander Hein MD,  Grit Mehlhorn MD,  Michael P. Lux MD,  Stefan P. Renner MD,  Achim Preisner MD,  Matthias W. Beckmann MD,  Michael G. Schrauder MD, 
  • Pages: 613-618
  • First Published: 04 July 2016

Obesity is not associated with increased morbidity in patients undergoing cytoreductive surgery with intraperitoneal chemotherapy

Madalyn G. Neuwirth MD,  Edmund K. Bartlett MD,  Robert E. Roses MD,  Douglas L. Fraker MD,  Rachel R. Kelz MD,  Giorgos C. Karakousis MD, 
  • Pages: 619-624
  • First Published: 07 July 2016

An initial report on the intraoperative use of indocyanine green fluorescence imaging in the surgical management of liver tumorss

Hideo Takahashi MD,  Nisar Zaidi MD,  Eren Berber MD, 
  • Pages: 625-629
  • First Published: 09 September 2016

Patient-centered outcomes to decide treatment strategy for patients with low rectal cancer

Michitaka Honda MD,  Takashi Akiyoshi MD,  Hisashi Noma PhD,  Atsushi Ogura MD,  Toshiya Nagasaki MD,  Tsuyoshi Konishi MD,  Yoshiya Fujimoto MD,  Satoshi Nagayama MD,  Yosuke Fukunaga MD,  Masashi Ueno MD, 
  • Pages: 630-636
  • First Published: 20 October 2016

Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer

Sunil V. Patel MD, MSc,  Campbell S. Roxburgh MD,  Efsevia Vakiani MD, PhD,  Jinru Shia MD,  J. Joshua Smith MD, PhD,  Larissa K. Temple MD,  Philip Paty MD,  Julio Garcia-Aguilar MD, PhD,  Garrett Nash MD, MPH,  Jose Guillem MD, MPH,  Abraham Wu MD,  Marsha Reyngold MD, PhD,  Martin R. Weiser MD, 
  • Pages: 637-641
  • First Published: 19 September 2016

Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors

Gianpiero Gravante MD, PhD,  David Hemingway MD,  James Andrew Stephenson MD,  David Sharpe,  Ahmed Osman MD,  Melissa Haines MD,  Vafa Pirjamali MD,  Roberto Sorge PhD,  Justin Ming Yeung MD,  Michael Norwood MD,  Andrew Miller MD,  Kirsten Boyle MD, 
  • Pages: 642-648
  • First Published: 07 July 2016

Letters to the Editor

Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma?

Amine Souadka MD,  Mohammed Anass Majbar MD,  Mohamed Raiss MD, 
  • Page: 649
  • First Published: 06 October 2016

In response: Can we rely on the adequate mesorectum excision and the complete pathological response in case of rectal signet-ring cell carcinoma

Leonardo S. Lino-Silva MD,  Miguel A. García-Gómez MD,  Rosa A. Salcedo-Hernández MD, 
  • Page: 650
  • First Published: 29 July 2016